Obstructive nephropathy

Kidney International

Volumn 54, Issue 1, 1998, Pages 286-300

  Klahr, Saulo ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

ACE inhibitors; Hydronephrosis; Obstructive nephropathy; Obstructive uropathy; Tubulointerstitial disease; Urinary tract obstruction

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; HUMAN; HYDRONEPHROSIS; KIDNEY DISEASE; NEPHROSTOMY; OBSTRUCTIVE UROPATHY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; URINARY TRACT OBSTRUCTION;

APOPTOSIS; FEMALE; FIBROSIS; HUMANS; HYDRONEPHROSIS; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; URETERAL NEOPLASMS; URETERAL OBSTRUCTION; UTERINE CERVICAL NEOPLASMS;

EID: 0031806819     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. KLAHR S: Nephrology Forum: Pathophysiology of obstructive nephropathy. Kidney Int 23:414-426, 1983
2. KLAHR S: Urinary tract obstruction, in Diseases of the Kidney (6th ed), edited by SCHRIER RW, GOTTSCHALK CW, Boston, Little, Brown, 1997, pp 709-738
3. NATIONAL KIDNEY, UROLOGIC DISEASES ADVISORY BOARD: The scope and impact of kidney and urologic diseases, in Long-Range Plan (chapt 1), Washington DC, National Institutes of Health, NIH Publication #90-583, 1990, pp 7-35
4. UNITED STATES RENAL DATA SYSTEM: Annual Data Report. II. Incidence and prevalence of ESRD, Am J Kidney Dis 18(suppl 2):S34-S47, 1996
5. PETERS CA: Obstruction of the fetal urinary tract. J Am Soc Nephrol 8:653-663, 1997
6. STRIKER GE, SCHAINUCK LI, CUTLER RE, BENDITT EP: Structural-functional correlations in renal diseases. I, A method for assaying and classifying histopathologic changes in renal disease. Hum Pathol 1:615-630, 1970
7. SCHAINUCK LI, STRIKER GE, CUTLER RE, BENDITT EP: Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1:631-641, 1970
8. BOHLE A, VON GISE H, MACKENSEN-HAEN S, STARK-JAKOB B: The obliteration of the postglomerular capillaries and its influence upon the function of both glomeruli and tubuli. Klin Wochenschr 59:1043-1051, 1981
9. BOHLE A, MACKENSEN-HAEN S, GISE H, ET AL: The consequences of tubulointerstitial changes for renal function in glomerulopathies, in Tubulointerstitial Nephropathies, edited by AMERIO A, CORTELLI P, MASSRY SE, Boston, Kluwer, 1991, pp 29-40
10. EDDY AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7:2495-2508, 1996
11. BRADY HR, ADLER S: Cell-cell and cell matrix interactions, in The Kidney (5th ed), edited by BRENNER BM, Philadelphia, Saunders, 1996, pp 193-210
12. NATH KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1-17, 1992
13. NAGLE RB, BULGER RE, CUTLER RE, JERVIS HR, BENDITT EP: Unilateral obstructive nephropathy in the rabbit. I. Early morphologic, physiologic and histological changes. Lab Invest 28:456-467, 1973
14. NAGLE RB, BULGER RE: Unilateral obstructive nephropathy in the rabbit. II. Late morphologic changes. Lab Invest 38:270-278, 1978
15. SHARMA AK, MAUER SM, KIM Y, MICHAEL AF: Interstitial fibrosis in obstructive nephropathy. Kidney Int 44:774-780, 1993
16. SCHREINER G, UNANUE ER: Origin of the rat mesangial phagocyte and its expression of leukocyte common antigen. Lab Invest 51:515-523, 1984
17. SCHREINER GF, HARRIS KPG, PURKERSON ML, KLAHR S: Immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney. Kidney Int 34:487-493, 1988
18. ROVIN BH, HARRIS KPG, MORRISON A, KLAHR S, SCHREINER GF: Renal cortical release of a specific macrophage chemoattractant in response to ureteral obstruction. Lab Invest 63:213-220, 1990
19. DIAMOND JR, KEES-FOLTS D, DING G, FRYE JE, RESTREPO NC: Macrophages, monocyte peptide-1, and TGF-β1 in experimental hydronephrosis. Am J Physiol 266:F926-F933, 1994
20. KANETO, H, MORRISSEY J, KLAHR S: Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ligation. Kidney Int 44:313-321, 1993
21. DIAMOND JR, KEES-FOLTS D, RICARDO SD, PRUZNAK A, EUFEMIO M: Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol 136:1455-1466, 1995
22. DUAN L, MORRISSEY J, MCCRACKEN R, KLAHR S: Regulation of MCP-1, ICAM-I and VCAM-I during unilateral ureteral obstruction (abstract). J Am Soc Nephrol 7:1697, 1996
23. HARRIS KPG, SCHREINER GF, KLAHR S: Effect of leukocyte depletion on the function of the post-obstructed kidney in the rat. Kidney Int 36:210-215, 1989
24. KANETO H, MORRISSEY J, MCCRACKEN R, REYES A, KIAHR S: Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 45:1637-1647, 1994
25. KUNCIO GS, NEILSON EG, HAVERTY T: Mechanisms of tubulointerstitial fibrosis. Kidney Im 39:550-556, 1991
26. ISHIDOYA S, MORRISSEY J, MCCRACKEN R, REYES A, KLAHR S: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral ligation. Kidney Int 47:1285-1294, 1995
27. DIAMOND JR, VAN GOOR H, DING G, ENGELMEYER E: Myofibroblasts in experimental hydronephrosis. Am J Pathol 146:121-129, 1995
28. KLAHR S, ISHIDOYA S, MORRISSEY J: Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis 26:141-146, 1995
29. ISHIDOYA S, MORRISSEY J, MCCRACKEN R, KLAHR S: Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats, Kidney Int 49:1110-1119, 1996
30. PIMENTEL JL, MARTINEZ-MALDONADO M, WILCOX JN, WANG S, LUO C: Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney Int 44:390-400, 1993
31. ROBERTS AM, SPORN MB: Transforming growth factor β. Adv Cancer Res 51:107-145, 1988
32. BORDER WA, RUOSLAUTI E: Transforming growth factor β in disease: The dark side of tissue repair. J Clin Invest 90:1-7, 1992
33. MUNGER JS, HARPEL JG, GLEIZES PE, MAZZIERI R, NUNES I, RIFKIN DB: Latent transforming growth factor β: Structural features and mechanisms of activation. Kidney Int 51:1376-1382, 1997
34. BÖTTINGER EP, LETTERIO JJ, ROBERTS AR: Biology of TGF-β in knockout and transgenic mouse models. Kidney Int 51:1355-1360, 1997
35. BORDER WA, NOBLE NA: Transforming growth factor-β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
36. GIBBONS GH, PRATT RE, DZAU VJ: Vascular smooth muscle hypertrophy. Autocrine transforming growth factor β1 expression determines growth response to angiotensin II. J Clin Invest 90:451-461, 1992
37. MORRISSEY J, ISHIDOYA S, MCCRACKEN R, KLAHR S: The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis. Kidney Int 49(suppl 54):S83-S87, 1996
38. ENGELMEYER E, VAN GOOR H, EDWARDS DR, DIAMOND JR: Differential mRNA expression of renal cortical tissue of metalloproteinase 1, -2, -3 in experimental hydronephrosis. J Am Soc Nephrol 5:1675-1683, 1995
39. DIAMOND JR, LEVINSON M, KREISBERG R, RICARDO SD: Increased expression of decorin in experimental hydronephrosis. Kidney Int 51:1133-1139, 1997
40. MORRISSEY J, ISHIDOYA S, MCCRACKEN R, KLAHR S: Control of p53 and p21 (WAF1) expression during unilateral ureteral obstruction. Kidney Int 50(suppl 57):S84-S92, 1996
41. HARTWELL LH, KASTAN MB: Cell cycle control and cancer. Science 26:1821-1828, 1994
42. EGIDO J, GOMEZ-CHIARRI M, ORTIZ A, BUSTOS C, ALONSO J, GOMEZ-GUERRERO C, GOMEZ-GARRE P, LOPEZ-ARMADA MJ, PLAZA J, GONZALEZ E: Role of tumor necrosis factor-α in the pathogenesis of glomerular diseases. Kidney Int 43(suppl 39):S59-S64, 1993
43. BAUD L, FOUQUERAY B, PHILIPPE C, AMRAM A: Tumor necrosis factor alpha and mesangial cells. Kidney Int 41:600-603, 1992
44. ORTIZ A, BUSTOS C, ALCAZAR A, LOPEZ-ARMADA MJ, PLAZA JU, GONZALEZ E, EGIDO J: Involvement of tumor necrosis factor α in the pathogenesis of experimental and human glomerulonephritis, in Advances in Nephrology, edited by GRÜNFELD JP, BACH JF, KREIS H, MAXWELL MH, St. Louis, Mosby, 1995, pp 53-77
45. WUTHRICH RP, GLIMCHFR LH, YUI MA, JEVNIKAR AM, DUMAS SE, KELLEY VE: MHC class II antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 37:783-792, 1990
46. KANETO H, MORRISSEY J, MCCRACKEN R, ISHIDOYA S, REYES A, KLAHR S: The expression of mRNA for tumor necrosis factor α increases in the obstructed kidney of rats soon after unilateral ureteral ligation. Nephrology 2:161-166, 1996
47. WOLF G, ABERLE S, THAISS F, NELSON PJ, KAENSKY AM, NEILSON EG, STRAHL RA: TNF-α induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int 44:795-804, 1993
48. MULLIGAN MS, JOHNSON KJ, TODD RF, ISSEKUTZ TB, MIYASAKA M, TAMATANI T, SMITH CW, ANDERSON DC, WARD PA: Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 91:577-587, 1993
49. LARRICK JW, WRIGHT SC: Cytotoxic mechanism of tumor necrosis factor-α. FASEB J 4:3215-3223, 1990
50. LASTER SM, WOOD JG, GOODING LR: Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J Immunol 141:2629-2634, 1988
51. ITOH N, YONKHARA S, ISHII A, YONEHARA M, MIZUSHIMA SI, SHAMESHIMA M, HASE A, SETO Y, NAGATA S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991
52. GOBE GC, AXELSEN RA: Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab Invest 56:273-281, 1987
53. KENNEDY WA II, STENBERG A, LACKGREW G, HENSTE TW, SAWEZUKI IS: Renal tubular apoptosis after partial ureteral obstruction. J Urol 152:658-664, 1994
54. BAEURLE PA, HENKEL T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179, 1994
55. BARNES PJ, KARIN M: Nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997
56. WENDT T, ZHANG YM, BIERHAUS A, KRIEGSMANN J, DENG Y, WAIDHERR R, TESKE T, LUTHER T, FÜNFSTUK R, NAWROTH PP, STEIN G: Tissue factor expression in an animal model of hydronephrosis. Nephrol Dial Transplant 10:1820-1828, 1995
57. MORRISSEY J, KLAHR S: Enalapril decreases nuclear factor κB activation in the kidney with ureteral obstruction. Kidney Int 52:926-933, 1997
58. KLAHR S, MORRISSEY J: Comparative study of ACE inhibitors and AII receptor antagonists in interstitial scarring. Kidney Int 52(suppl 63): S111-S114, 1997
59. BRASIER AR, LI J, WIMBISH KA: Tumor necrosis factor activates angiotensinogen by the Rel A transactivator. Hypertension 27:1009-1017, 1996
60. GOBE G, FUNG LCT, BUTTYAN R: Hallmark and consequences of apoptosis and necrosis in the kidney, in Contemporary Issues in Nephrology (vol 30), "Acute Renal Failure," edited by GOLIGORSKY MS, STEIN JH, New York, Churchill-Livingstone, 1995, pp 143-159
61. SCHUMER M, COLOMBEL MC, SAWCZUK IS, GOBE G, CONNOR J, O'TOOLE KM, OLSSON CA, WISE GJ, BUTTYAN R: Morphological, biochemical and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140:831-838, 1992
62. EVAN GI, WYLLIE AH, GILBERT CS, LITTLEWOOD TD, LAND H, BROOKS M, WATERS CM, PENN LS, HANCOCK DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128, 1992
63. SAVILL J: Apoptosis and the kidney. J Am Soc Nephrol 5:12-21, 1994
64. TRUONG LD, PETRUSEVSKA G, YANG G, GURMIPAR T, SHAPPELL S, LECHAGO J, ROUSE D, SUKI WN: Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int 50:200-207, 1996
65. MØLLER JC, JØRGENSON TM, MORTENSEN J: Proximal tubular atrophy: Qualitative and quantitative structural changes in chronic obstructive nephropathy in the pig. Cell Tissue Res 244:479-491, 1986
66. MØLLER JC, SKRIVER E: Quantitative ultrastructure of human proximal tubules and cortical interstitium in chronic renal disease (hydronephrosis). Virchows Arch [A] 406:389-406, 1985
67. MORRISSEY JJ, ISHIDOYA S, MCCRACKEN R, KLAHR S: Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 7:2202-2212, 1996
68. MODI KS, MORRISSEY J, SHAH SV, SCHREINER GF, KLAHR S: Effects of probucol on renal function in rats with bilateral ureteral obstruction. Kidney Int 38:843-850, 1990
69. RICARDO SK, DING G, EUFEMIO M, DIAMOND JR: Antioxidant expression in experimental hydronephrosis: Role of mechanical stretch and growth factors. Am J Physiol 272 (Renal Fluid Electrol Physiol 4):F789-F798, 1997
70. MORRISSEY J, DUAN L, KLAHR S: N-acetylcysteine treatment alters nuclear transcription factor activity and monocyte infiltration during ureteral obstruction (abstract). J Am Soc Nephrol 7:1830, 1996
71. SCHMITT-GRAFF A, DESMOULIÈRE A, GABBIANI G: Heterogeneity of myofibroblast features: An example of fibroblastic cell plasticity. Virchowx Arch 425:3-24, 1994
72. ALPERS CE, PICHLER R, JOHNSON RJ: Phenotypic features of cortical interstitial cells potentially important in fibrosis. Kidney Int 49(suppl 54):S28-S31, 1996
73. EL NAHAS AM, MUCHANETA-KUBARA EC, ZHANG GZ, ADAM A, GOUMENOS D: Phenotypic modulation of renal cells during experimental and clinical scarring. Kidney Int 49(suppl 54):S23-S27, 1996
74. TANG WW, ULICH TR, LACKY DI, HILL DC, QI M, KAUFMAN SA, VAN GY, TARPLEY JE, YEE JS: Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 148:1169-1180, 1996
75. JOHNSON RJ, ALPERS CE, YOSHIMURA A, LOMBARDI D, PRITZI P, FLOEGE J, SCHWARTZ SW: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
76. LAFAYETTR R, MAYKR G, MEYER T: The effect of blood pressure reduction on cyclosporine nephrotoxicity in the rat. J Am Soc Nephrol 3:1892-1899, 1993
77. JONES CL, BUCH S, POST M, MCCULLOCH L, LIU E, EDDY AA: Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. Kidney Int 40:1020-1031, 1991
78. YOUNG BA, JOHNSON RJ, ALPERS CE, ENG E, GORDON K, FLOFGE J, COUSER WG: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47:935-944, 1995
79. ZOJA C, DONADELLI R, CORNA D, TESTA D, FACCHINETTI D, MAFFI R, LUZZANA E, COLOSIO V, BFRTANI T, REMUZZI G: The renoprotective properties of angiotensin- converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis 29:254-264, 1997
80. DIAMOND JR, ANDERSON S: Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition. Am J Pathol 137:1323-1332, 1990
81. NAKAMURA T, TAKAHASHI T, FUKUI M, EBIHARA I, OSADA S, TOMINO Y, KOIDE H: Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. J Am Soc Nephrol 5:1492-1497, 1995
82. VAUGHAN ED, GILLENWATER JY: Recovery following complete unilateral ureteral occlusion. J Urol 106:27-35, 1971
83. SOER JR: Temporary obstruction of the ureter: An experimental study of the recovery of renal function after reversible obstruction of the ureter in the rabbit. Arch Chir Neerl 26:77-86, 1974
84. KERR WS JR: Effect of complete ureteral obstruction in dogs on kidney function. Am J Physiol 184:521-526, 1956
85. BETTER OS, ARIEFF AI, MASSRY SG, KLEEMAN CR, MAXWELL MH: Studies on renal function after relief of complete unilateral ureteral obstruction of three months' duration in man. Am J Med 54:234-240, 1973
86. BASILE DP, ROVAK IM, MARTIN DR, HAMMERMAN MR: Increased transforming growth factor-β1 expression in regenerating rat renal tubules following ischemic injury. Am J Physiol 270:F500-F509, 1996
87. BASILE DP, LIAPIS H, HAMMERMAN MR: Expression of bcl-2 and bax in regenerating rat renal tubules following ischemic injury. Am J Physiol 272:F640-F647, 1997
88. MDRD GROUP: Blood pressure control, proteinuria and the progression of renal disease: The Modification of Diet in Renal Disease Study. Ann Intern Med 123:754-762, 1995
89. MARTIN KJ, FREITAG JJ, BELLORIN-FONT E, CONRADES MB, KLAHR S, SLATOPOLSKY E: The effect of acute acidosis on the uptake of parathyroid hormone and the production of adenosine 3′-5′ monophosphate by isolated perfused bone. Endocrinology 106:1607-1611, 1980
90. KRIEGER NS, SESSLER NE, BUSHINSKY DA: Acidosis inhibits osteoblastic and stimulates osteoclastic activity. Am J Physiol 262:F442-F448, 1992
91. FINE LG, ONG ACM, NORMAN JR: Mechanisms of tubulointerstitial injury in progressive renal diseases. Ear J Clin Invest 23:259-264, 1993